Who Is at Risk for Osteoporosis

Osteoporosis, meaning “porous bones”, is a condition that causes bones to gradually thin and weaken, leaving them susceptible to fractures. With an aging population, osteoporosis is becoming increasingly common in America. After age 50, 50% of women and 25% of men are at significant risk for osteoporosis.

In the United States, more than 10 million men and women have osteoporosis. A further 34 million people have low bone mass and are at high risk of developing osteoporosis. About 1.5 million fractures occur each year due to osteoporosis.

Inflammation Accelerates Bone Loss

Osteoporosis, like heart disease, cancer, and diabetes, is not a natural consequence of aging. Rather, chronic degenerative diseases usually arise from long-term nutritional, lifestyle, and environmental imbalances that lead to buildup of inflammatory toxins.

Although the exact cause of osteoporosis is unknown, the process by which bone becomes porous is well understood. Bone remodeling is regulated by a variety of hormones and inflammatory cytokines. When the body is exposed to inflammatory toxins, bone breakdown is outpacing bone buildup or bone resorption occurs at a faster rate than bone production. Both processes could lead to bone loss and osteoporosis.

Clinical studies have shown that increased inflammatory cytokines are primary mediators of the accelerated bone loss at menopause. Different studies report increases in the risk of developing osteoporosis in various inflammatory conditions, including rheumatoid arthritis, inflammatory bowel diseases (IBD), periodontitis, and multiple myeloma. In periodontal disease, oral inflammation results in destruction of oral bone and periodontal ligament, ultimately leading to tooth loss. Further evidence suggests that a variety of inflammatory cytokines activate osteoclasts, bone cells that remove the bone tissue and cause bone resorption.

Osteoporosis Drugs May Cause Sever Pain

Several prescription drugs can reduce bone loss and prevent osteoporosis. However, the FDA has issued a new warning for osteoporosis drugs, called bisphosphonates (marketed as Actonel, Actonel+Ca, Aredia, Boniva, Didronel, Fosamax, Fosamax+D, Reclast, Skelid, and Zometa) may lead to severe, chronic, and even permanent pain in muscle joints and bones. Read
Diabetes Drugs May Thin the Bones

A popular class of drugs for type 2 diabetes, thiazolidinediones (marketed as Avandia and Actos), had already been linked to heart problems. Recent study showed that using these diabetes drugs for more than a year thins the bones and doubles the risk of fractures in women with type 2 diabetes, who are already at higher risk before taking the therapy. Read

Alternative Approaches for Osteoporosis

In addition to calcium, vitamin D, and physical therapy, estrogen-containing hormone replacement therapy is very effective in reversing the impact of menopause on bone density. But it is currently out of favor due to unwanted side effects, including increased risk of stroke, venous thrombosis and, possibly, dementia. Other treatments include anti-resorptive or anabolic medications.

FlameEz-Bone Offers Unique Approach for Long-Term Benefits

FlameEz-Bone is a patent pending natural remedy scientifically formulated according to the advanced medical discovery that chronic inflammation promotes bone breakdown and suppresses bone buildup. Different from other bone remedies, FlameEz-Bone remedy relieves systemic inflammation and supports current treatment for osteoporosis. Additionally, carefully selected natural ingredients in FlameEz-Bone ensure safe and long-term use.